Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04066218 · ClinicalTrials.gov registry record
Sexual Function Screening in Childhood Cancer Survivors
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 24
- Enrollment target
NCT04066218: Completed study, sponsored by University of Colorado, Denver.
NCT04066218 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04066218 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.
Primary Outcome
Qualitative interviews will be conducted by phone by a trained qualitative research interviewer. Interviews will be in-depth and semistructured, utilizing a combination of broad, open-ended questions and more specific probes. The interview guide was developed with the help of Dr. Michael Fisher, PhD, who has expertise in qualitative research methodology. The interviewer will take detailed field notes. This portion of the interview will last approximately 25-35 minutes and will be digitally recor
Interventions
- OTHER Interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2022-06-01 |
What the finished NCT04066218 record still lists
NCT04066218 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interviews is the first listed.
NCT04066218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04066218 about?
NCT04066218 is a clinical study titled "Sexual Function Screening in Childhood Cancer Survivors". This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.
What is the current status of trial NCT04066218?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2019-09-16. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT04066218?
The interventions under investigation include: Interviews (OTHER).
Who is sponsoring clinical trial NCT04066218?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI